Autoimmune diseases are a group of conditions that occur when the immune system mistakenly attacks the body’s own cells, causing inflammation and damage to various organs and tissues. Some of the most common autoimmune diseases include multiple sclerosis, type 1 diabetes, Crohn’s disease, rheumatoid arthritis, and lupus. According to the World Health Organization, more than 80 million people worldwide suffer from autoimmune diseases, and the number is expected to rise in the coming years.
Currently, there is no cure for autoimmune diseases, and the available treatments are often limited by side effects, toxicity, or lack of efficacy. However, a new type of vaccine developed by researchers at the University of Chicago, University of Michigan, Cornell University, Northwestern University, and University of Bristol could change that. The vaccine, dubbed as an “inverse vaccine”, can reverse autoimmune diseases by erasing the immune system’s memory of one molecule that triggers the attack.
“We call it an ‘inverse vaccine’ because instead of inducing immunity to a foreign molecule, it induces tolerance to a self-molecule,” said Jeffrey Hubbell, Eugene Bell Professor in Tissue Engineering at the Pritzker School of Molecular Engineering (PME) at the University of Chicago and senior author of the study.
The inverse vaccine works by coupling an antigen, a molecule being attacked by the immune system, with a molecule resembling a fragment of an aged cell that the liver would recognize as friend. When injected into the bloodstream, the vaccine travels to the liver, where it is taken up by specialized immune cells called Kupffer cells. These cells then present the antigen to other immune cells called regulatory T cells, which suppress the immune response against the antigen and induce tolerance.
“The beauty of this approach is that it essentially trains the immune system to ignore one specific molecule, without affecting anything else,” said Ankur Singh, associate professor in the Sibley School of Mechanical and Aerospace Engineering at Cornell University and co-senior author of the study.
The inverse vaccine can stop the autoimmune reaction even after there is already ongoing inflammation, which is a major challenge for conventional therapies. The vaccine also takes advantage of the natural mechanism of peripheral immune tolerance, which prevents autoimmune reactions to cells that die by natural processes.
“This is a completely new approach to treating autoimmune diseases, and we hope it will be safe and effective for many conditions,” said Lonnie Shea, Steven A. Goldstein Collegiate Professor of Biomedical Engineering at the University of Michigan and co-senior author of the study.
The inverse vaccine has been tested in mice and shown to be effective in treating multiple sclerosis and type 1 diabetes, two of the most prevalent and debilitating autoimmune diseases. The researchers also believe that the vaccine has potential to treat other autoimmune diseases such as Crohn’s disease, rheumatoid arthritis, and lupus.
“This is a very promising strategy that could potentially be used to treat many different types of autoimmune diseases. It could also be applied to prevent organ rejection after transplantation or to desensitize patients with food or drug allergies,” said Dr. David Wraith, professor of immunology at the University of Bristol and director of the Institute of Immunology and Immunotherapy.
The researchers are now planning to conduct further studies to optimize the vaccine formulation and delivery, as well as to test its efficacy in other animal models and human cells. They are also collaborating with biotechnology companies to translate their findings into clinical trials.
“This is a major breakthrough in immunotherapy research because we were able to use purified cells, instead of whole organisms, to generate the vaccine,” said Stephen Miller, Judy Gugenheim Research Professor of Microbiology-Immunology at Northwestern University Feinberg School of Medicine and co-senior author of the study. “We hope that this will pave the way for a new era of personalized medicine for autoimmune diseases.”
Relevant articles:
– “Inverse vaccine” shows potential to treat multiple sclerosis and other autoimmune diseases, Pritzker School of Molecular Engineering, University of Chicago, September 11, 2023
– Multiple sclerosis: ‘Inverse vaccine’ may help reverse conditions, Medical News Today, September 17, 2023
– Autoimmune Disorder Treatment: New Vaccine May Completely Reverse Diseases, The Health Site, September 14, 2023
– New Vaccine Can Completely Reverse Autoimmune Diseases Like Multiple Sclerosis, Type 1 Diabetes, and Crohn’s Disease, SciTechDaily, September 14, 2023